Novavax Inc (NVAX)

EBITDA

-$205.59M

TTM · Period ending: · USD

NVAX logo

NVAX EBITDA

Latest reported-$205.59M
NVAX TTM EBITDA (-$4.80M → -$205.59M)
High-resolution chart · PNG

NVAX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-10,188,000
-12,164,000
-12,148,000
-8,349,000
-6,676,000
-4,753,000
-4,200,000
-4,800,000
-4,400,000
-4,900,000
-4,900,000
-4,300,000
-4,200,000
-4,200,000
-4,400,000
-5,100,000
-4,900,000
-4,800,000
-4,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.